1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

10 Mar 2026
Admin
News Article

Crescent Pharma Limited Recalls Ramipril Batch After Packaging Error

A precautionary recall has been issued by Crescent Pharma Limited for one batch of Ramipril 5 mg capsules after a packaging error was discovered.

The recall affects batch number GR164099. The issue came to light after a pharmacy reported that a carton labelled Ramipril contained blister strips of Amlodipine 5 mg tablets instead. Both medicines are widely used to treat high blood pressure

How the Error Happened?

According to the Medicines and Healthcare products Regulatory Agency (MHRA), the error likely occurred during secondary packaging, when blister strips were placed into cartons.

Key details of the issue include:

A sealed Ramipril carton containing blister strips of Amlodipine tablets
Both medicines manufactured at the same production site
A packaging mix-up during the cartoning stage

The problem was detected after a patient complaint reported by a pharmacy.

What Patients Should Do?

The MHRA advises patients taking Ramipril to check their medicine packs carefully. Follow these steps:

Look for batch number GR164099 on the outer carton
Check whether the blister strips match the medicine name on the box
If blister strips say Amlodipine, return the pack to your pharmacist

If the blister strips are correctly labelled Ramipril 5 mg capsules, no further action is needed.

Health Risk Considered Low

Health authorities say the risk to patients is very low. Both medicines treat high blood pressure, although they belong to different drug classes. However, if someone accidentally takes Amlodipine instead of Ramipril, they may experience:

Lower-than-normal blood pressure
Dizziness

MHRA Guidance for Patients

Shareen Doak, Deputy Director of Benefit-Risk Evaluation at the MHRA, urged patients to check their medication packaging.

“If you take Ramipril, check the packaging for batch number GR164099 and confirm the blister strips match the medicine name on the carton.”

Patients who believe they may have taken the incorrect medication and are experiencing symptoms should seek medical advice immediately.

They are also encouraged to report any adverse reactions through the MHRA Yellow Card Scheme.

Guidance for Pharmacies and Healthcare Professionals

The MHRA has instructed pharmacies and healthcare providers to:

Stop dispensing the affected batch
Return remaining stock to suppliers

About the UK Medicines Regulator

The Medicines and Healthcare products Regulatory Agency regulates medicines and medical devices in the United Kingdom.

The agency operates under the Department of Health and Social Care and ensures that medical products are safe, effective, and provide benefits that outweigh potential risks.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!